Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khandan Keyomarsi

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
The Journal of Biological Chemistry|January 1, 2004
Activation of cyclin-dependent kinase 2 by full length and low molecular weight forms of cyclin E in breast cancer cellsRichard M Harwell, Benjamin B Mull, Donald C Porter, et al.
Cell Cycle (Georgetown, Tex.)|March 19, 2010
Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cellsBaohua Sun, Hannah Wingate, Stephen G Swisher, et al.
Expert Opinion on Investigational Drugs|August 14, 2018
Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapySiqing Fu, Yudong Wang, Khandan Keyomarsi, et al.
Cancer Research|March 10, 2011
Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin ESaid Akli, Carolyn S Van Pelt, Tuyen Bui, et al.
Breast Cancer Research and Treatment|December 25, 2008
Cyclin E deregulation is an early event in the development of breast cancerAlexandra Shaye, Aysegul Sahin, Qiang Hao, et al.
Cancer Research|June 10, 2010
Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25CRozita Bagheri-Yarmand, Angela Nanos-Webb, Anna Biernacka, et al.
Cancer Research|December 7, 2007
Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein betaTomoya Yokota, Tuyen Bui, Yanna Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
Cyclin E-associated kinase activity predicts response to platinum-based chemotherapyIsabelle Bedrosian, Christine Lee, Susan L Tucker, et al.
Molecular Oncology|March 23, 2013
EVI1 splice variants modulate functional responses in ovarian cancer cellsPunashi Dutta, Tuyen Bui, Kyle A Bauckman, et al.
The Journal of Biological Chemistry|February 15, 2005
The tumor-specific hyperactive forms of cyclin E are resistant to inhibition by p21 and p27Hannah Wingate, Ning Zhang, Mollianne J McGarhen, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
The Journal of Biological Chemistry|January 1, 2004
Activation of cyclin-dependent kinase 2 by full length and low molecular weight forms of cyclin E in breast cancer cellsRichard M Harwell, Benjamin B Mull, Donald C Porter, et al.
Cell Cycle (Georgetown, Tex.)|March 19, 2010
Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cellsBaohua Sun, Hannah Wingate, Stephen G Swisher, et al.
Expert Opinion on Investigational Drugs|August 14, 2018
Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapySiqing Fu, Yudong Wang, Khandan Keyomarsi, et al.
Cancer Research|March 10, 2011
Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin ESaid Akli, Carolyn S Van Pelt, Tuyen Bui, et al.
Breast Cancer Research and Treatment|December 25, 2008
Cyclin E deregulation is an early event in the development of breast cancerAlexandra Shaye, Aysegul Sahin, Qiang Hao, et al.
Cancer Research|June 10, 2010
Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25CRozita Bagheri-Yarmand, Angela Nanos-Webb, Anna Biernacka, et al.
Cancer Research|December 7, 2007
Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein betaTomoya Yokota, Tuyen Bui, Yanna Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
Cyclin E-associated kinase activity predicts response to platinum-based chemotherapyIsabelle Bedrosian, Christine Lee, Susan L Tucker, et al.
Molecular Oncology|March 23, 2013
EVI1 splice variants modulate functional responses in ovarian cancer cellsPunashi Dutta, Tuyen Bui, Kyle A Bauckman, et al.
The Journal of Biological Chemistry|February 15, 2005
The tumor-specific hyperactive forms of cyclin E are resistant to inhibition by p21 and p27Hannah Wingate, Ning Zhang, Mollianne J McGarhen, et al.
Pageof 11